| Issue Date | Title | Author(s) |
| 2013 | Amlodipine/valsartan 5/160 mg versus valsartan 160 mg in Chinese hypertensives | Zhu, Dingliang; Yang, Kan; Sun, Ningling; Gao, Pingjin; Wang, Ruonan; Grosso, Amie; Zhang, Ying |
| 2023 | Design, synthesis and biological activity evaluation of novel covalent S-acylation inhibitors | Yu, Wei; Yang, Kan; Zhao, Mengmiao; Liu, Han; You, Zhihao; Liu, Zhenming; Qiao, Xiaoqiang; Song, Yali |
| 2023 | Design, synthesis and biological activity evaluation of novel covalent S-acylation inhibitors | Yu, Wei; Yang, Kan; Zhao, Mengmiao; Liu, Han; You, Zhihao; Liu, Zhenming; Qiao, Xiaoqiang; Song, Yali |
| 5-Apr-2023 | Design, synthesis and biological evaluation of dual Topo II/HDAC inhibitors bearing pyrimido[5,4-b]indole and pyrazolo[3,4-d] pyrimidine motifs | Zhao, Mengmiao; Yang, Kan; Zhu, Xinyue; Gao, Tian; Yu, Wei; Liu, Han; You, Zhihao; Liu, Zhenming; Qiao, Xiaoqiang; Song, Yali |
| 2012 | Efficacy and safety of aliskiren, a direct renin inhibitor, compared with ramipril in Asian patients with mild to moderate hypertension | Zhu, Jun-Ren; Sun, Ning-Ling; Yang, Kan; Hu, Jian; Xu, Geng; Hong, Huashan; Wang, Ruonan; Tu, Ying-Mei; Ritter, Shannon; Keefe, Deborah |
| 2016 | Efficacy and Safety of Fixed-Dose Perindopril Arginine/Amlodipine in Hypertensive Patients Not Adequately Controlled with Amlodipine 5 mg or Perindopril tert-Butylamine 4 mg Monotherapy | Hu, Dayi; Sun, Yihong; Liao, Yuhua; Huang, Jing; Zhao, Ruiping; Yang, Kan |
| 18-Jan-2022 | Magnetically Controlled Capsule Endoscopy for Assessment of Antiplatelet Therapy-Induced Gastrointestinal Injury | Han, Yaling; Liao, Zhuan; Li, Yi; Zhao, Xianxian; Ma, Shuren; Bao, Dan; Qiu, Miaohan; Deng, Jie; Wang, Jinhai; Qu, Peng; Jiang, Chunmeng; Jia, Shaobin; Yang, Shaoqi; Ru, Leisheng; Feng, Jia; Gao, Wei; Huang, Yonghui; Tao, Ling; Han, Ying; Yang, Kan; Wang, Xiaoyan; Zhang, Wenjuan; Wang, Bangmao; Li, Yue; Yang, Youlin; Li, Junxia; Sheng, Jiangqiu; Ma, Yitong; Cui, Min; Ma, Sicong; Wang, Xiaozeng; Li, Zhaoshen; Stone, Gregg W. |
| 15-Jan-2023 | Pyrazolo [3,4-d]pyrimidine-based dual HDAC/Topo II inhibitors: Design, synthesis, and biological evaluation as potential antitumor agents | Dong, Jinjiao; Zhu, Xinyue; Yu, Wei; Hu, Xiaotong; Zhang, Yiwen; Yang, Kan; You, Zhihao; Liu, Zhenming; Qiao, Xiaoqiang; Song, Yali |
| 15-Aug-2020 | Synthesis and biological evaluation of novel pyrazoline derivatives containing indole skeleton as anti-cancer agents targeting topoisomerase II | Song, Yali; Feng, Siran; Feng, Jiajia; Dong, Jinjiao; Yang, Kan; Liu, Zhenming; Qiao, Xiaoqiang |
| Mar-2022 | Synthesis and biological evaluation of xanthone derivatives as anti-cancer agents targeting topoisomerase II and DNA | Song, Yali; Zhu, Xinyue; Yang, Kan; Feng, Siran; Zhang, Yiwen; Dong, Jinjiao; Liu, Zhenming; Qiao, Xiaoqiang |
